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The 1997 IARC Evaluation
In 1997 the International Agency for
Research on Cancer (IARC) classiﬁed TCDD
(2,3,7,8-tetrachlorodibenzo-p-dioxin, the
most potent dioxin congener) as a group 1
carcinogen (IARC 1997) based on limited evi-
dence in humans, sufficient evidence in ani-
mals, and extensive mechanistic information
indicating that TCDD acts through a mecha-
nism involving the aryl hydrocarbon receptor
(AhR), which is present in both humans and
animals. The 1997 IARC evaluation updated
an older, obsolete evaluation that had classi-
ﬁed TCDD as a group 2B (possible) human
carcinogen. IARC’s criteria for “limited” evi-
dence for the epidemiologic studies requires
that a causal interpretation is “credible,” but
that chance, bias, or confounding cannot be
ruled out as the source of the observed associ-
ation. TCDD was unprecedented in that it
was judged to cause an increase in cancers at
all sites rather than at a few speciﬁc sites. This
judgment was supported by both the epi-
demiologic and animal data. In animals, there
were no “hallmark” sites that were elevated;
instead, different tumor sites were elevated in
different species in different studies.
Furthermore, tissue concentrations were simi-
lar both in heavily exposed human popula-
tions, in which increased overall cancer risk
was observed, and in rats exposed to carcino-
genic dosage regimens in bioassays. At the
1997 IARC meeting held 4–11 February in
Lyon, France, there was consensus that the
epidemiologic evidence was at least “limited,”
with some consideration that it was “suffi-
cient.” The main discussion and division of
opinions concerned the use of mechanistic
data to interpret cancer risk in humans.
In 1997, the epidemiologic evidence con-
sisted of studies of a) several industrial cohorts
of chemical workers producing chlorophenol
and phenoxy herbicides; b) cohorts of civilian
or military pesticide applicators; c) the Seveso
accident cohort; and d) numerous community-
based studies. The IARC working group on
dioxins summarized all of the available data
but based the epidemiologic evaluation on
studies of four highly exposed subcohorts
within the industrial cohorts, and on the
Seveso cohort. The main criteria for relying on
these studies were principally that the cohorts
included subjects with levels clearly higher
than background and that exposure was well
characterized. The four industrial cohorts are
listed in Table 1, which also deﬁnes the subco-
horts and their all-cancer mortality in reference
to external populations. Exposure information
is also given in Table 1 in terms of parts per
trillion in serum. To put this in context, the
general population has serum levels of approxi-
mately ≤ 5 ppt, and levels have been gradually
decreasing in recent decades (Aylward and
Hays 2002; IARC 1997; Schecter et al. 2003).
The four industrial subcohorts were consistent
in showing signiﬁcant although moderate ele-
vations of cancer mortality. When the data
were combined, the standardized mortality
ratio for all four subcohorts was 1.40 [95%
conﬁdence interval (CI), 1.1–1.7]. An expo-
sure–response analysis was available in 1997
for two of the four cohorts (Flesch-Janys et al.
1995; Ott and Zober 1996); both of these
analyses showed a signiﬁcant positive exposure
response for all cancers. Confounding by
smoking or by other chemicals was judged to
be unlikely to explain the observed consistent
all-cancer excess.
Evidence Published after 1997
New exposure–response analyses. Since the
IARC monograph on dioxins (IARC 1997),
there have been several new exposure–response
analyses using the industrial cohorts (Table 1).
These analyses have used similar techniques to
develop estimates of serum TCDD levels for
all workers in the cohort.
Using a newly developed job-exposure
matrix (JEM) (Piacitelli et al. 2000), Steenland
et al. (1999) analyzed exposure–response
analysis in the NIOSH (National Institute for
Occupational Safety and Health) cohort using
cumulative exposure scores. The JEM was
based on knowledge of the amount of TCDD
contamination in the chemicals produced in
each of eight plants in the study, knowledge of
plant processes over time, and knowledge of
what the job of each worker was across time.
Each job in each plant was assigned an expo-
sure score by the JEM. The exposure score rep-
resented a relative ranking of exposure for each
worker. The rate ratios for all cancers (mortal-
ity) by septile of cumulative exposure score
(15-year lag) were 1.00, 1.00, 1.29, 1.38, 1.43,
1.88, and 1.76 (p-value for trend < 0.001).
Steenland et al. (1999) used data on exposure
scores and serum level, which were available
for 170 workers, to determine the relationship
between exposure score and serum level. This
enabled assignment of estimated serum level,
based on the exposure score, for all workers
(n = 3,538) in the study (Steenland et al.
2001). Analyses by septile of estimated cumu-
lative serum level resulted in rate ratios for all
cancers of 1.00, 1.26, 1.02, 1.43, 1.46, 1.82,
and 1.62 (p-value for trend = 0.003).
Additional analyses of the Dutch cohort
(Hooiveld et al. 1998) used a similar approach.
Serum TCDD levels from 144 workers were
used to build a model to predict serum levels
based on duration of exposure, exposure during
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In 1997 the International Agency for Research on Cancer (IARC) classified 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD; the most potent dioxin congener) as a group 1 carcinogen based
on limited evidence in humans, sufﬁcient evidence in experimental animals, and extensive mecha-
nistic information indicating that TCDD acts through a mechanism involving the aryl hydro-
carbon receptor (AhR), which is present in both humans and animals. The judgment of limited
evidence in humans was based primarily on an elevation of all cancers combined in four industrial
cohorts. The group 1 classiﬁcation has been somewhat controversial and has been challenged in
the literature in recent years. In this article we review the epidemiologic and mechanistic evidence
that has emerged since 1997. New epidemiologic evidence consists primarily of positive exposure–
response analyses in several of the industrial cohorts, as well as evidence of excesses of several spe-
ciﬁc cancers in the Seveso accident cohort. There are also new data regarding how the AhR func-
tions in mediating the carcinogenic response to TCDD. The new evidence generally supports the
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Research Commentaryan accident, and exposure before 1970.
Predicted serum TCDD values from the
model were assigned to the whole cohort of
1,031 workers. Workers were then classified
as having received low, medium, or high
exposure based on predicted serum TCDD
values. Workers who received medium and
high exposures had signiﬁcant 5-fold increases
in cancer mortality compared with workers at
the same plant with low dioxin exposure.
Becher et al. (1998) and Flesch-Janys et al.
(1998) used a similar approach to further ana-
lyze a German cohort in detailed exposure–
response analyses. TCDD levels from a sample
of 275 workers were used to construct a model
based on job, age, and body mass index. This
model predicted TCDD values over time for
all 1,189 members of the cohort. These
authors then used these data to estimate time-
dependent cumulative exposure to TCDD in
the serum for each cohort member. Prior
analyses had been restricted to a ﬁxed estimate
of serum TCDD at the end of exposure. Rate
ratios for all-cancer mortality by categorized
ppt-years of TCDD were 1.00, 1.12, 1.42,
1.77, 1.63, and 2.19 (p-value for trend = 0.03)
(Becher et al. 1998).
Crump et al. (2003) conducted a meta-
analysis of three of these cohorts (Flesch-Janys
1998; Ott and Zober 1996; Steenland et al.
1999) and found a positive and significant
exposure–response trend for all cancers.
Crump et al. (2003) also showed that the slope
of the dose response was not dependent on the
pattern of the risk in heavily exposed workers
and that, by contrast, the slope was slightly
steeper at lower doses.
Harking back to Austin Bradford Hill and
his criteria for assessing causation (Hill 1965),
positive exposure–response analyses are impor-
tant in supporting the assessment of causality.
Furthermore, the dose–response analyses are
internal comparisons among workers and are
unlikely to be affected by confounding from
occupational, lifestyle, or other factors related
to socioeconomic status. These positive expo-
sure–response analyses for TCDD since the
IARC classiﬁcation (IARC 1997) strengthen
the decision by IARC to label TCDD a
human carcinogen.
New results from Seveso. Besides the new
exposure–response findings, there has been
new information from the Seveso cohort,
which was exposed during an accident in Italy
in 1976 (Bertazzi and di Domenico 2003).
This cohort was exposed at one time to quite
high levels of TCDD. People in zone A (the
most highly exposed zone) had a median
serum TCDD level of 72 ppt in 1992–1993
(back-extrapolated level to 1976, 379 ppt). In
Seveso, exposure to nearly “pure” TCDD was
well documented and affected all ages and
both sexes. The exposed and reference popu-
lations both lived in a fairly homogeneous
area and shared environmental, occupational,
social, and cultural features. The limitations of
the cohort are that the number of highly
exposed subjects is relatively small and that fol-
low-up has been of relatively short duration.
However, recent data have shown significant
cancer excesses that were not previously evi-
dent in this cohort.
Among those with relatively high exposure
at Seveso (zones A and B), all-cancer mortality
in the 20-year postaccident period and all-can-
cer incidence in the 15-year postaccident
period failed to exhibit signiﬁcant departures
from the expected (Bertazzi et al. 2001;
Pesatori et al. 2003). Among men, however,
after 20 years of follow-up, both all-cancer
(166 deaths) and lung cancer mortality
(57 deaths) tended to be higher than expected
[all cancer: relative risk (RR) = 1.1; 95% CI,
1.0–1.3; lung cancer: RR = 1.3; 95% CI,
1.0–1.7]. Furthermore, some specific cancer
sites were significantly elevated. For lym-
phopoietic neoplasms, signiﬁcant increases in
mortality (20 years; RR = 1.7; 95% CI,
1.2–2.5) and morbidity (15-year latency;
RR = 1.8; 95% CI, 1.2–2.6) were observed,
consistent in both sexes. Furthermore, there
was an increase in rectal cancer mortality in
men (RR = 2.4; 95% CI, 1.2–4.6); a corre-
sponding increase was seen for incidence.
Among women, liver cancer incidence was ele-
vated in the 15-year postaccident period
(RR = 2.4; 95% CI, 1.1–5.1). Finally, in a
separate analysis of 981 women in zone A who
had stored serum, breast cancer incidence was
signiﬁcantly related to serum TCDD levels (a
2-fold increase for a 10-fold increase in serum
TCDD), based on a limited number of cases
(n = 15) (Warner et al. 2002).
Other new studies. Another cohort with
well-documented exposure, based on serum
TCDD levels, is the Ranch Hand cohort of
Air Force personnel who sprayed Agent
Orange in Vietnam. This cohort was not
exposed to TCDD at the high levels of the
industrial cohorts but nonetheless was exposed
to levels considerably beyond background. For
example, the mean serum TCDD level in the
mid-1980s was 46 ppt (geometric mean, 15),
compared with a mean of 233 ppt among the
NIOSH cohort in the late 1980s (Fingerhut
et al. 1991). Until recently, the Ranch Hand
cohort had not shown any cancer excesses,
and the number of cancers was small.
Although there is still no overall cancer excess
[standardized incidence ratio (SIR) = 1.07), in
the most recent update (through 1999) of this
cohort, Akhtar et al. (2004) found a signifi-
cant excess of melanoma [(SIR = 2.57; 95%
CI, 1.52–4.09) when comparing Ranch
Hand personnel with the general population
(16 cases)]. This excess did not appear among
other Air Force personnel who were also in
Southeast Asia in the 1960s but did not spray
Agent Orange. Furthermore, there appeared
to be an exposure–response trend, using sev-
eral different measures of exposure. Akhtar
et al. (2004) also found excesses of prostate
cancer incidence, but these occurred in both
exposed and nonexposed Air Force personnel
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Table 1. Four industrial cohorts that served as a basis for IARC (1997) TCDD determination.
Study originally Cancer SMR (95% CI) No. of
available to IARC and deﬁnition cancer Estimated TCDD at Exposure–response
in 1997a of subcohort deaths end of exposureb data for TCDD
Fingerhut et al. 1991 1.5 (1.2–1.8), 114 Mean 418 ppt Positive signiﬁcant trend
> 1 year exposure, (n = 119) (p < 0.001, p = 0.003)
20 years of latency in Steenland et al.
(59% of cohort) (1999, 2001),c based on
JEM and serum levels
Becher et al. 1996 1.3 (1.0–1.5), 105 Plant 1: mean, 141 ppt Positive signiﬁcant
workers in two (n = 190) trend (p < 0.01) in
plants with Plant 2: mean, 402 ppt Flesch-Janys et al. (1995),
documented (n = 20) in Flesch-Janys et al. (1998;
chloracne and p = 0.01),c and in
high serum Becher et al. (1998;
TCDD levels p = 0.03),c based on
JEM and serum levels
Hooiveld et al. 1996 1.5 (1.3–1.9), 51 Geometric mean, Medium- and
workers in the 286 ppt (n = 48) high-exposure
most highly groups elevated
exposed plant (RRs = 4.7 and 4.1) versus
(n = 549) low (Hooiveld et al. 1998),c
based on work history
and serum levels
Ott and Zober 1996 1.9 (1.1–3.0), 18 Geometric mean, Positive signiﬁcant trend
chloracne and 400 ppt (n = 138) (p = 0.05) in original 1996
≥ 20 years’ publication, based on
latency (n = 113) body burden
Abbreviations: CI, conﬁdence interval; NIOSH, National Institute for Occupational Safety and Health; SMR, standardized
mortality ratio.
aIARC (1997; Table 38). bIARC (1997; Table 22). cPost-1997 ﬁndings.and may have been due to increased cancer
surveillance in both groups; both are subject
to intense medical follow-up.
Other dioxin studies published since 1997
include a study of Army Chemical Corps vet-
erans who did or did not serve in Vietnam
(Dalager et al. 1997), and an update of a sub-
cohort contained within the NIOSH cohort
(Bodner et al. 2003). The studies are largely
uninformative because the numbers are quite
small or because exposure is uncertain
(Dalager et al. 1997).
Dioxin Risk Assessments
A separate issue is whether the findings that
high levels of TCDD exposure lead to cancer
has relevance for those exposed at low doses,
that is, the general public. The classification
of TCDD as a human carcinogen in 1997
strengthened the pressure to lower human
exposure and was followed by subsequent
World Health Organization (WHO) risk
assessments that lowered considerably the
accepted tolerable daily intake from previously
set limits (WHO 1998, 2001). There have
also been several cancer risk assessment efforts
to date (Becher et al. 1998; Crump et al.
2003; Starr 2001; Steenland et al. 2001; U.S.
EPA 2000) using data on the high-exposure
industrial cohorts to estimate risk at low
doses. It should be noted that some of the
high-exposure cohorts did have a fair number
of low-exposed subjects, so the usual problem
of extrapolating findings from high dose to
low dose is not as pronounced as for some
other agents for which risk assessment has
been based on occupational cohorts. Nearly
all these assessments concur in showing an
appreciable excess risk of cancer due to rela-
tively small increases above background levels.
In the general population, such increases
would be due to increased TCDD in the diet.
New Evidence on the AhR
Apart from new epidemiologic data since 1997,
there are also new experimental studies (some
of them used in the recent WHO risk assess-
ments) and advances in the understanding of
mechanisms of action of dioxins, particularly
concerning the AhR. The AhR is a nuclear
receptor and transcription factor. In the pres-
ence of TCDD, it forms an active heterodimer
with the aromatic hydrocarbon nuclear trans-
locator (ARNT/HIF-1β) and induces (or sup-
presses) the transcription of numerous genes,
including P4501A1 (CYP1A1) (Whitlock
1999). In the last few years, additional compo-
nents of the AhR complex have been identiﬁed,
including the AhR repressor, AhR-interacting
protein (also known as XAP2), Rb protein,
receptor-interacting protein 140, SRC-1, p23,
and the RelA NF-κB subunit (Carlson and
Perdew 2002; Kumar and Perdew 1999;
Mimura et al. 1999; Petrulis and Perdew
2002). Molecular mechanisms occurring down-
stream of AhR and possibly associated with
cancer development, such as changes in cyto-
solic signaling proteins, calcium mobilization,
tumor suppressor proteins, growth factors,
oncogenes, and cell cycle proteins, have been
characterized (Carlson and Perdew 2002; Enan
et al. 1998; Matsumura 2003).
Recently, molecular epidemiology investi-
gations have been conducted on random sam-
ples of the Seveso population highly exposed to
TCDD (zones A and B) and from the refer-
ence noncontaminated area (non-ABR) to
evaluate how TCDD exposure affects the AhR
pathway in human subjects in vivo (Baccarelli
et al. 2004; Landi et al. 2003). Because of the
extremely long biologic half-life of TCDD,
plasma TCDD levels were still substantially
elevated in the exposed subjects, particularly in
females and older subjects (Landi et al. 1997).
Experimental studies indicate that, after a tran-
sient increase, cellular levels of AhR decrease
following TCDD binding (Pollenz 2002).
Nearly 20 years after the Seveso accident, the
levels of AhR transcripts  (measured in uncul-
tured peripheral blood lymphocytes) were
decreased in the exposed subjects and nega-
tively correlated with current plasma TCDD
levels (Landi et al. 2003). These results show
that TCDD exposure causes a persistent altera-
tion of the AhR pathway in human subjects
and are consistent with down-regulation of this
receptor, comparable with that observed in sev-
eral other receptor-mediated systems (Pollenz
2002). The impact on the health of exposed
individuals of the persistent decrease of AhR
transcripts, which in turn may affect any AhR-
regulated biologic function, is to be clariﬁed.
Down-regulation tends to decrease the amount
of receptor available for ligand binding and to
attenuate the resulting biologic responses.
Thus, the AhR, like most receptor systems,
may have high initial sensitivity to the ligand,
whereas in the presence of high amounts of
TCDD, down-regulation would buffer against
excessive ligand-induced responses. High initial
levels of exposure, rather than low persisting
exposures, may be associated with the highest
effects. In the industrial cohorts, cumulative
exposure predicts cancer excess. However, it is
likely that cumulative and peak exposures are
highly correlated among industrial workers.
The new evidence from animal studies and on
the AhR should be used to reﬁne quantitative
risk assessment of TCDD and could modify
estimates on tolerable intake in humans. This
evidence, put together, supports the approach
taken by IARC to consider the animal and
mechanistic data in the evaluation of carcino-
genicity of these compounds in humans.
Conclusion
The IARC classification of TCDD as a
group 1 carcinogen (IARC 1997) has stirred
some controversy. For example, Cole et al.
(2003) argue that the original IARC classiﬁca-
tion of epidemiologic evidence for TCDD as
“limited” (IARC 1997) was incorrect, claiming
that “inadequate” would have been more
appropriate (i.e., a causal interpretation was
not “credible”). However, these authors
ignored the original IARC focus on high-
exposure subcohorts, ignored the positive
exposure–response analyses, and raised the
issue of possible confounding by smoking and
other chemical carcinogens without any serious
consideration of whether such possible con-
founding is likely, or whether it could account
for the observed elevation of all-cancer mortal-
ity in those with higher TCDD exposure.
In our view, the epidemiologic and toxico-
logic evidence since the IARC (1997) classiﬁca-
tion of TCDD as a human carcinogen has
strengthened the case for IARC’s decision.
Furthermore, the dose–response assessments
for TCDD and cancer indicate that TCDD
exposure levels close to those in the general
population may be carcinogenic and argue for
caution in setting the upper ranges of long-
term permissible exposure to dioxins.
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